Fig. 2From: LMP2-mRNA lipid nanoparticle sensitizes EBV-related tumors to anti-PD-1 therapy by reversing T cell exhaustionAnti-tumor effect of C2@mLMP2 combing αPD-1. A Experimental flow. B The Tumor growth curve of the four groups (Tukey’s multiple comparisons test p-value: **** < 0.0001 < *** < 0.001 < ** < 0.01 < * < 0.05). C Tumors images on Day 11. D Mice images on Day 11. E H&E staining of tumor tissuesBack to article page